Poly-Adenosine diphosphatase Ribose Polymerase inhibitor(English)
- HGSOC patients with deleterious germline or somatic mutations in BRCA1 or BRCA2 are most responsive
- BRCAm, HGSOC, OC, PARP, VEGFR, BRCA, EOC, HR
- Ovary and uterus, Oncology, Therapeutic approaches
- https://doi.org…84.2016.1156857
- https://doi.org…3048-019-0579-0